Synthesis of azo bonded immunoregulatory compounds

134 1 4 2 5 1 4 67 8 1 4 Methods are disclosed for preparing compounds of Formula I: where R, R, and Rare independently hydrogen or Cto Calkyl, and Ris: where Ris selected from the group consisting of hydrogen and Cto Calkyl, or where R, Rand Rare independently hydrogen or Cto Calkyl; or the esters...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Riggs-Sauthier, Jennifer A, Ekwuribe, Nnochiri N
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Riggs-Sauthier, Jennifer A
Ekwuribe, Nnochiri N
description 134 1 4 2 5 1 4 67 8 1 4 Methods are disclosed for preparing compounds of Formula I: where R, R, and Rare independently hydrogen or Cto Calkyl, and Ris: where Ris selected from the group consisting of hydrogen and Cto Calkyl, or where R, Rand Rare independently hydrogen or Cto Calkyl; or the esters or pharmacologically acceptable salts thereof. The methods can involve converting a suitably functionalized aniline compound to a diazonium salt (which aniline compound can be first formed by reduction of a nitrobenzene) and coupling the diazonium salt with a suitably functionalized benzene compound. The suitably functionalized aniline compound either includes a primary alcohol or aldehyde group, which is then oxidized to a carboxylic acid group, or includes a nitrile or amide group, which is hydrolyzed to a carboxylic acid group. The methods can also involve the direct coupling (via reduction of nitro groups to form an azo linkage) of suitably functionalized nitrobenzenes. The compounds and or their metabolites can be used to treat or prevent various diseases, particularly inflammatory conditions of the GI tract.
format Patent
fullrecord <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_07932366</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>07932366</sourcerecordid><originalsourceid>FETCH-uspatents_grants_079323663</originalsourceid><addsrcrecordid>eNrjZDAKrswryUgtzixWyE9TSKzKV0jKz0tJTVHIzM0tzcsvSk0vzUksyS-qVEjOzy3IL81LKeZhYE1LzClO5YXS3AwKbq4hzh66pcUFiSWpeSXF8elFiSDKwNzS2MjYzMyYCCUA6h0tvw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Synthesis of azo bonded immunoregulatory compounds</title><source>USPTO Issued Patents</source><creator>Riggs-Sauthier, Jennifer A ; Ekwuribe, Nnochiri N</creator><creatorcontrib>Riggs-Sauthier, Jennifer A ; Ekwuribe, Nnochiri N ; Biocon Limited</creatorcontrib><description>134 1 4 2 5 1 4 67 8 1 4 Methods are disclosed for preparing compounds of Formula I: where R, R, and Rare independently hydrogen or Cto Calkyl, and Ris: where Ris selected from the group consisting of hydrogen and Cto Calkyl, or where R, Rand Rare independently hydrogen or Cto Calkyl; or the esters or pharmacologically acceptable salts thereof. The methods can involve converting a suitably functionalized aniline compound to a diazonium salt (which aniline compound can be first formed by reduction of a nitrobenzene) and coupling the diazonium salt with a suitably functionalized benzene compound. The suitably functionalized aniline compound either includes a primary alcohol or aldehyde group, which is then oxidized to a carboxylic acid group, or includes a nitrile or amide group, which is hydrolyzed to a carboxylic acid group. The methods can also involve the direct coupling (via reduction of nitro groups to form an azo linkage) of suitably functionalized nitrobenzenes. The compounds and or their metabolites can be used to treat or prevent various diseases, particularly inflammatory conditions of the GI tract.</description><language>eng</language><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7932366$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,780,802,885,64038</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7932366$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Riggs-Sauthier, Jennifer A</creatorcontrib><creatorcontrib>Ekwuribe, Nnochiri N</creatorcontrib><creatorcontrib>Biocon Limited</creatorcontrib><title>Synthesis of azo bonded immunoregulatory compounds</title><description>134 1 4 2 5 1 4 67 8 1 4 Methods are disclosed for preparing compounds of Formula I: where R, R, and Rare independently hydrogen or Cto Calkyl, and Ris: where Ris selected from the group consisting of hydrogen and Cto Calkyl, or where R, Rand Rare independently hydrogen or Cto Calkyl; or the esters or pharmacologically acceptable salts thereof. The methods can involve converting a suitably functionalized aniline compound to a diazonium salt (which aniline compound can be first formed by reduction of a nitrobenzene) and coupling the diazonium salt with a suitably functionalized benzene compound. The suitably functionalized aniline compound either includes a primary alcohol or aldehyde group, which is then oxidized to a carboxylic acid group, or includes a nitrile or amide group, which is hydrolyzed to a carboxylic acid group. The methods can also involve the direct coupling (via reduction of nitro groups to form an azo linkage) of suitably functionalized nitrobenzenes. The compounds and or their metabolites can be used to treat or prevent various diseases, particularly inflammatory conditions of the GI tract.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZDAKrswryUgtzixWyE9TSKzKV0jKz0tJTVHIzM0tzcsvSk0vzUksyS-qVEjOzy3IL81LKeZhYE1LzClO5YXS3AwKbq4hzh66pcUFiSWpeSXF8elFiSDKwNzS2MjYzMyYCCUA6h0tvw</recordid><startdate>20110426</startdate><enddate>20110426</enddate><creator>Riggs-Sauthier, Jennifer A</creator><creator>Ekwuribe, Nnochiri N</creator><scope>EFH</scope></search><sort><creationdate>20110426</creationdate><title>Synthesis of azo bonded immunoregulatory compounds</title><author>Riggs-Sauthier, Jennifer A ; Ekwuribe, Nnochiri N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_079323663</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2011</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Riggs-Sauthier, Jennifer A</creatorcontrib><creatorcontrib>Ekwuribe, Nnochiri N</creatorcontrib><creatorcontrib>Biocon Limited</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Riggs-Sauthier, Jennifer A</au><au>Ekwuribe, Nnochiri N</au><aucorp>Biocon Limited</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Synthesis of azo bonded immunoregulatory compounds</title><date>2011-04-26</date><risdate>2011</risdate><abstract>134 1 4 2 5 1 4 67 8 1 4 Methods are disclosed for preparing compounds of Formula I: where R, R, and Rare independently hydrogen or Cto Calkyl, and Ris: where Ris selected from the group consisting of hydrogen and Cto Calkyl, or where R, Rand Rare independently hydrogen or Cto Calkyl; or the esters or pharmacologically acceptable salts thereof. The methods can involve converting a suitably functionalized aniline compound to a diazonium salt (which aniline compound can be first formed by reduction of a nitrobenzene) and coupling the diazonium salt with a suitably functionalized benzene compound. The suitably functionalized aniline compound either includes a primary alcohol or aldehyde group, which is then oxidized to a carboxylic acid group, or includes a nitrile or amide group, which is hydrolyzed to a carboxylic acid group. The methods can also involve the direct coupling (via reduction of nitro groups to form an azo linkage) of suitably functionalized nitrobenzenes. The compounds and or their metabolites can be used to treat or prevent various diseases, particularly inflammatory conditions of the GI tract.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_grants_07932366
source USPTO Issued Patents
title Synthesis of azo bonded immunoregulatory compounds
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T05%3A02%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Riggs-Sauthier,%20Jennifer%20A&rft.aucorp=Biocon%20Limited&rft.date=2011-04-26&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E07932366%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true